Global Erectile Dysfunction Market Research Report 2025

Publication ID:

PB503257070

Publication Date:

March 27, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Erectile Dysfunction was valued at US$ 6340 million in the year 2024 and is projected to reach a revised size of US$ 10140 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The erectile dysfunction (ED) drug market is experiencing significant growth. The main drivers of market growth include the increase in the elderly population, increased awareness of ED, innovation in treatment methods, and favorable reimbursement policies.
The prevalence of ED is rising globally, with an estimated 15% of men affected by ED each year and expected to affect 320 million people by 2025. The incidence of ED increases with age, and the growth of the elderly population is one of the key factors driving the growth of the ED drugs market.
Technological advancements such as new drug development, innovations in drug delivery systems such as sublingual tablets, topical creams, and nasal sprays are also driving market growth. Additionally, the rise of telemedicine services is changing how ED treatment is obtained.
The market is highly concentrated, with major players including Bayer, Eli Lilly, Pfizer, Teva and other companies. These companies strengthen their market positions by launching new drugs, expanding product portfolios and market coverage.
In terms of products, sildenafil (Viagra) held the largest market share in 2023, followed by tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra).
In terms of route of administration, oral drugs accounted for the largest market share in 2023, and other routes, including topical and intraurethral delivery, are expected to grow at the fastest rate.
From a regional perspective, North America is the largest market, accounting for more than 40% of the market share, followed by Asia Pacific and Europe.
Overall, the ED drugs market is driven by several factors, including increasing geriatric population, changing lifestyles, technological advancements, and rising awareness about ED treatments. The market is expected to continue to expand as new drugs and new treatment modalities are developed.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction.
The Erectile Dysfunction market size, estimations, and forecasts are provided in terms of sales volume (Million Pill) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Erectile Dysfunction market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erectile Dysfunction manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erectile Dysfunction in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Erectile Dysfunction Market Overview
1.1 Product Definition
1.2 Erectile Dysfunction by Type
1.2.1 Global Erectile Dysfunction Market Value Comparison by Type (2024 VS 2031)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction by Application
1.3.1 Global Erectile Dysfunction Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Global Erectile Dysfunction Market Size Estimates and Forecasts
1.4.1 Global Erectile Dysfunction Revenue 2020-2031
1.4.2 Global Erectile Dysfunction Sales 2020-2031
1.4.3 Global Erectile Dysfunction Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Erectile Dysfunction Market Competition by Manufacturers
2.1 Global Erectile Dysfunction Sales Market Share by Manufacturers (2020-2025)
2.2 Global Erectile Dysfunction Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Erectile Dysfunction Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Erectile Dysfunction, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Erectile Dysfunction, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Erectile Dysfunction, Product Type & Application
2.7 Global Key Manufacturers of Erectile Dysfunction, Date of Enter into This Industry
2.8 Global Erectile Dysfunction Market Competitive Situation and Trends
2.8.1 Global Erectile Dysfunction Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Erectile Dysfunction Players Market Share by Revenue
2.8.3 Global Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Erectile Dysfunction Market Scenario by Region
3.1 Global Erectile Dysfunction Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Erectile Dysfunction Sales by Region: 2020-2031
3.2.1 Global Erectile Dysfunction Sales by Region: 2020-2025
3.2.2 Global Erectile Dysfunction Sales by Region: 2026-2031
3.3 Global Erectile Dysfunction Revenue by Region: 2020-2031
3.3.1 Global Erectile Dysfunction Revenue by Region: 2020-2025
3.3.2 Global Erectile Dysfunction Revenue by Region: 2026-2031
3.4 North America Erectile Dysfunction Market Facts & Figures by Country
3.4.1 North America Erectile Dysfunction Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Erectile Dysfunction Sales by Country (2020-2031)
3.4.3 North America Erectile Dysfunction Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Erectile Dysfunction Market Facts & Figures by Country
3.5.1 Europe Erectile Dysfunction Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Erectile Dysfunction Sales by Country (2020-2031)
3.5.3 Europe Erectile Dysfunction Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erectile Dysfunction Market Facts & Figures by Region
3.6.1 Asia Pacific Erectile Dysfunction Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Erectile Dysfunction Sales by Region (2020-2031)
3.6.3 Asia Pacific Erectile Dysfunction Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Erectile Dysfunction Market Facts & Figures by Country
3.7.1 Latin America Erectile Dysfunction Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Erectile Dysfunction Sales by Country (2020-2031)
3.7.3 Latin America Erectile Dysfunction Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erectile Dysfunction Market Facts & Figures by Country
3.8.1 Middle East and Africa Erectile Dysfunction Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Erectile Dysfunction Sales by Country (2020-2031)
3.8.3 Middle East and Africa Erectile Dysfunction Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Erectile Dysfunction Sales by Type (2020-2031)
4.1.1 Global Erectile Dysfunction Sales by Type (2020-2025)
4.1.2 Global Erectile Dysfunction Sales by Type (2026-2031)
4.1.3 Global Erectile Dysfunction Sales Market Share by Type (2020-2031)
4.2 Global Erectile Dysfunction Revenue by Type (2020-2031)
4.2.1 Global Erectile Dysfunction Revenue by Type (2020-2025)
4.2.2 Global Erectile Dysfunction Revenue by Type (2026-2031)
4.2.3 Global Erectile Dysfunction Revenue Market Share by Type (2020-2031)
4.3 Global Erectile Dysfunction Price by Type (2020-2031)
5 Segment by Application
5.1 Global Erectile Dysfunction Sales by Application (2020-2031)
5.1.1 Global Erectile Dysfunction Sales by Application (2020-2025)
5.1.2 Global Erectile Dysfunction Sales by Application (2026-2031)
5.1.3 Global Erectile Dysfunction Sales Market Share by Application (2020-2031)
5.2 Global Erectile Dysfunction Revenue by Application (2020-2031)
5.2.1 Global Erectile Dysfunction Revenue by Application (2020-2025)
5.2.2 Global Erectile Dysfunction Revenue by Application (2026-2031)
5.2.3 Global Erectile Dysfunction Revenue Market Share by Application (2020-2031)
5.3 Global Erectile Dysfunction Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Company Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Erectile Dysfunction Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eli Lilly Erectile Dysfunction Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Erectile Dysfunction Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Erectile Dysfunction Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Erectile Dysfunction Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Erectile Dysfunction Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 BaiYunShan General Factory
6.4.1 BaiYunShan General Factory Company Information
6.4.2 BaiYunShan General Factory Description and Business Overview
6.4.3 BaiYunShan General Factory Erectile Dysfunction Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BaiYunShan General Factory Erectile Dysfunction Product Portfolio
6.4.5 BaiYunShan General Factory Recent Developments/Updates
6.5 S.K. Chemicals
6.5.1 S.K. Chemicals Company Information
6.5.2 S.K. Chemicals Description and Business Overview
6.5.3 S.K. Chemicals Erectile Dysfunction Sales, Revenue and Gross Margin (2020-2025)
6.5.4 S.K. Chemicals Erectile Dysfunction Product Portfolio
6.5.5 S.K. Chemicals Recent Developments/Updates
6.6 Teva Pharma
6.6.1 Teva Pharma Company Information
6.6.2 Teva Pharma Description and Business Overview
6.6.3 Teva Pharma Erectile Dysfunction Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharma Erectile Dysfunction Product Portfolio
6.6.5 Teva Pharma Recent Developments/Updates
6.7 Dong-A ST
6.7.1 Dong-A ST Company Information
6.7.2 Dong-A ST Description and Business Overview
6.7.3 Dong-A ST Erectile Dysfunction Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Dong-A ST Erectile Dysfunction Product Portfolio
6.7.5 Dong-A ST Recent Developments/Updates
6.8 Petros Pharmaceuticals
6.8.1 Petros Pharmaceuticals Company Information
6.8.2 Petros Pharmaceuticals Description and Business Overview
6.8.3 Petros Pharmaceuticals Erectile Dysfunction Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Petros Pharmaceuticals Erectile Dysfunction Product Portfolio
6.8.5 Petros Pharmaceuticals Recent Developments/Updates
6.9 Seoul Pharma
6.9.1 Seoul Pharma Company Information
6.9.2 Seoul Pharma Description and Business Overview
6.9.3 Seoul Pharma Erectile Dysfunction Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Seoul Pharma Erectile Dysfunction Product Portfolio
6.9.5 Seoul Pharma Recent Developments/Updates
6.10 Yabang Pharmacy
6.10.1 Yabang Pharmacy Company Information
6.10.2 Yabang Pharmacy Description and Business Overview
6.10.3 Yabang Pharmacy Erectile Dysfunction Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Yabang Pharmacy Erectile Dysfunction Product Portfolio
6.10.5 Yabang Pharmacy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erectile Dysfunction Industry Chain Analysis
7.2 Erectile Dysfunction Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erectile Dysfunction Production Mode & Process Analysis
7.4 Erectile Dysfunction Sales and Marketing
7.4.1 Erectile Dysfunction Sales Channels
7.4.2 Erectile Dysfunction Distributors
7.5 Erectile Dysfunction Customer Analysis
8 Erectile Dysfunction Market Dynamics
8.1 Erectile Dysfunction Industry Trends
8.2 Erectile Dysfunction Market Drivers
8.3 Erectile Dysfunction Market Challenges
8.4 Erectile Dysfunction Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂